Development of a Thermogelling Ophthalmic Formulation of Cysteine

Author： Dumortier G.   El Kateb N.   Sahli M.   Kedjar S.   Boulliat A.   Chaumeil J. C.  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.32, Iss.1, 2006-02, pp. : 63-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol

By  

Current Drug Delivery, Vol. 15, Iss. 4, 2018-04 ,pp. : 594-600

Bentham Science Publishers

Access to resources Recommend Favorite

Environmentally Responsive Ophthalmic Gel Formulation of Carteolol Hydrochloride

By El-Kamel Amal   Al-Dosari Heba   Al-Jenoobi Fahad  

Drug Delivery, Vol. 13, Iss. 1, 2006-01 ,pp. : 55-59

Informa Healthcare

Access to resources Recommend Favorite

Considerations in the use of hydroxypropyl- -cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone

By Bary A.R.   Tucker I.G.   Davies N.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 237-244

Elsevier

Access to resources Recommend Favorite

Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-01 ,pp. : 294-322

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation Development for Hydrophobic Therapeutic Proteins

By Hawe Andrea   Frieß Wolfgang  

Pharmaceutical Development and Technology, Vol. 12, Iss. 3, 2007-05 ,pp. : 223-237

Informa Healthcare

Access to resources Recommend Favorite